PublizoomAward notice Supplies
2026/0429- Concurso público internacional para aquisição de medicamentos
Notice published in Portuguese. The AI analysis summarises it for you in your language.
- Public buyer
- OUTRAS INSTITUIÇÕES DE SAÚDE
Todas - Place of performance
- Todas
- Estimated value
- €10,272,738 excl. VAT
- Amount awarded
- €1,362,736 excl. VAT
- Bids received
- 1
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 23 September 2026
- Notice language
- Portuguese
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
2026/0429- Concurso público internacional para aquisição de medicamentos
Awarded to
11 lots
- AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- FRASCO
- AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- FRASCO
- AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- SERINGA
- AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- SERINGA
- NINTEDANIB [100MG; CÁPS]
- NINTEDANIB [100MG; CÁPS]
- NINTEDANIB [150MG; CÁPS]
- NINTEDANIB [150MG; CÁPS]
- NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]
- NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]
- NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €247,856
- Median
- €358,774
- A quarter above
- €902,500
Amounts awarded (excl. VAT) over the last 3 years for 49 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Binimetinib 45 mg comp Unidade Local de Saúde de Coimbra, EPE · 23 October 2026 |
Pierre Fabre Medicament Portugal, Lda. | €309,520 |
| 2026/0006 - Carfilzomib [60 mg pó sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
AMGEN BIOFARMACEUTICA, LDA | €655,674 |
| 2026/0006 - Olaparib [150 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
ASTRAZENECA- PROD.FARM LDA | €266,176 |
| 2026/0098 - Agalsidase beta [35 mg f/amp] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
SANOFI-PRODUTOS FARMACÊUTICOS,LDA | €252,123 |
| 2024/0782 - Dexametasona [700 µg impl intravítreo emb] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
ABBVIE, LDA | €258,751 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 655857-2026.